Learn more

INTERVET INC

Overview
  • Total Patents
    209
  • GoodIP Patent Rank
    8,845
  • Filing trend
    ⇧ 90.0%
About

INTERVET INC has a total of 209 patent applications. It increased the IP activity by 90.0%. Its first patent ever was published in 1980. It filed its patents most often in United States, Denmark and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are INTERVET INTERNESHNL B V, SANOFI PASTEUR INC and IMMUNE DESIGN CORP.

Patent filings per year

Chart showing INTERVET INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Heckeroth Anja Regina 20
#2 Lutz Jürgen 16
#3 Tarpey Ian 16
#4 Morsey Mohamad 15
#5 O'Connell Kevin 14
#6 Fuchs Stefan 13
#7 Williams Heike 12
#8 Zhang Yuanzheng 12
#9 Zoller Hartmut 11
#10 Jacobs Antonius Arnoldus Christiaan 11

Latest patents

Publication Filing date Title
US2020026904A1 Automated parasite analysis system
US2020288680A1 System for external fish parasite monitoring in aquaculture
WO2019121900A1 Method and system for external fish parasite monitoring in aquaculture
US2020289634A1 Canine lyme disease vaccine
US2020338186A1 Feline calicivirus vaccine
US2020323978A1 Recombinant non-pathogenic marek's disease virus constructs encoding multiple heterologous antigens
US2020206336A1 A vaccine for protection against streptococcus suis
US2020206340A1 A vaccine comprising a pcv2 orf2 protein of genotype 2b
US2020085935A1 Combination vaccine for swine
US2020115367A1 Aminopyrazoles as selective janus kinase inhibitors
US2018371097A1 Caninized human antibodies to human il-4r alpha
US2019144831A1 Immortalised chicken embryonic epithelial kidney cells
US2018199595A1 Zilpaterol animal premix formulation
AU2015286634A1 Use of anthelmintic agents against Dirofilaria immitis
US2017114320A1 Method to sporulate coccidial oocysts purified from animal faeces, sporulated oocysts obtained with this method and a vaccine containing these sporulated oocysts
US2016313330A1 Diagnostic test for CSFV antibodies
US2016303220A1 Immortalized porcine alveolar macrophage
US2014271710A1 Liquid stable bovine virus vaccines
US2014271709A1 Bovine virus vaccines that are liquid stable
US2014234900A1 Methods for the release of Virus-like Particles